The Intriguing Effects of Substituents in the <i>N</i>-Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of “Tail Wags Dog” Experiments

(−)-<i>N</i>-Phenethyl analogs of optically pure <i>N</i>-norhydromorphone were synthesized and pharmacologically evaluated in several in vitro assays (opioid receptor binding, stimulation of [<sup>35</sup>S]GTPγS binding, forskolin-induced cAMP accumulation assay...

Full description

Bibliographic Details
Main Authors: Meining Wang, Thomas C. Irvin, Christine A. Herdman, Ramsey D. Hanna, Sergio A. Hassan, Yong-Sok Lee, Sophia Kaska, Rachel Saylor Crowley, Thomas E. Prisinzano, Sarah L. Withey, Carol A. Paronis, Jack Bergman, Saadet Inan, Ellen B. Geller, Martin W. Adler, Theresa A. Kopajtic, Jonathan L. Katz, Aaron M. Chadderdon, John R. Traynor, Arthur E. Jacobson, Kenner C. Rice
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/11/2640
_version_ 1797565918518181888
author Meining Wang
Thomas C. Irvin
Christine A. Herdman
Ramsey D. Hanna
Sergio A. Hassan
Yong-Sok Lee
Sophia Kaska
Rachel Saylor Crowley
Thomas E. Prisinzano
Sarah L. Withey
Carol A. Paronis
Jack Bergman
Saadet Inan
Ellen B. Geller
Martin W. Adler
Theresa A. Kopajtic
Jonathan L. Katz
Aaron M. Chadderdon
John R. Traynor
Arthur E. Jacobson
Kenner C. Rice
author_facet Meining Wang
Thomas C. Irvin
Christine A. Herdman
Ramsey D. Hanna
Sergio A. Hassan
Yong-Sok Lee
Sophia Kaska
Rachel Saylor Crowley
Thomas E. Prisinzano
Sarah L. Withey
Carol A. Paronis
Jack Bergman
Saadet Inan
Ellen B. Geller
Martin W. Adler
Theresa A. Kopajtic
Jonathan L. Katz
Aaron M. Chadderdon
John R. Traynor
Arthur E. Jacobson
Kenner C. Rice
author_sort Meining Wang
collection DOAJ
description (−)-<i>N</i>-Phenethyl analogs of optically pure <i>N</i>-norhydromorphone were synthesized and pharmacologically evaluated in several in vitro assays (opioid receptor binding, stimulation of [<sup>35</sup>S]GTPγS binding, forskolin-induced cAMP accumulation assay, and MOR-mediated β-arrestin recruitment assays). “Body” and “tail” interactions with opioid receptors (a subset of Portoghese’s message-address theory) were used for molecular modeling and simulations, where the “address” can be considered the “body” of the hydromorphone molecule and the “message” delivered by the substituent (tail) on the aromatic ring of the <i>N</i>-phenethyl moiety. One compound, <i>N</i>-<i>p</i>-chloro-phenethynorhydromorphone ((7a<i>R</i>,12b<i>S</i>)-3-(4-chlorophenethyl)-9-hydroxy-2,3,4,4a,5,6-hexahydro-1<i>H</i>-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7a<i>H</i>)-one, <b>2i</b>), was found to have nanomolar binding affinity at MOR and DOR. It was a potent partial agonist at MOR and a full potent agonist at DOR with a δ/μ potency ratio of 1.2 in the ([<sup>35</sup>S]GTPγS) assay. Bifunctional opioids that interact with MOR and DOR, the latter as agonists or antagonists, have been reported to have fewer side-effects than MOR agonists. The <i>p</i>-chlorophenethyl compound <b>2i</b> was evaluated for its effect on respiration in both mice and squirrel monkeys. Compound <b>2i</b> did not depress respiration (using normal air) in mice or squirrel monkeys. However, under conditions of hypercapnia (using air mixed with 5% CO<sub>2</sub>), respiration was depressed in squirrel monkeys.
first_indexed 2024-03-10T19:19:42Z
format Article
id doaj.art-413521e5240a47c49d66570b815acccf
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T19:19:42Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-413521e5240a47c49d66570b815acccf2023-11-20T03:02:43ZengMDPI AGMolecules1420-30492020-06-012511264010.3390/molecules25112640The Intriguing Effects of Substituents in the <i>N</i>-Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of “Tail Wags Dog” ExperimentsMeining Wang0Thomas C. Irvin1Christine A. Herdman2Ramsey D. Hanna3Sergio A. Hassan4Yong-Sok Lee5Sophia Kaska6Rachel Saylor Crowley7Thomas E. Prisinzano8Sarah L. Withey9Carol A. Paronis10Jack Bergman11Saadet Inan12Ellen B. Geller13Martin W. Adler14Theresa A. Kopajtic15Jonathan L. Katz16Aaron M. Chadderdon17John R. Traynor18Arthur E. Jacobson19Kenner C. Rice20Department of Health and Human Services, Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 9800 Medical Center Drive, Bethesda, MD 20892-3373, USADepartment of Health and Human Services, Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 9800 Medical Center Drive, Bethesda, MD 20892-3373, USADepartment of Health and Human Services, Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 9800 Medical Center Drive, Bethesda, MD 20892-3373, USADepartment of Health and Human Services, Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 9800 Medical Center Drive, Bethesda, MD 20892-3373, USADepartment of Health and Human Services, Center for Molecular Modeling, Office of Intramural Research, Center for Information Technology, National Institutes of Health, Bethesda, MD 20892, USADepartment of Health and Human Services, Center for Molecular Modeling, Office of Intramural Research, Center for Information Technology, National Institutes of Health, Bethesda, MD 20892, USADepartment of Medicinal Chemistry, School of Pharmacy, University of Kansas, Lawrence, KS 66045-7582, USADepartment of Medicinal Chemistry, School of Pharmacy, University of Kansas, Lawrence, KS 66045-7582, USADepartment of Medicinal Chemistry, School of Pharmacy, University of Kansas, Lawrence, KS 66045-7582, USABehavioral Biology Program, McLean Hospital/Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USABehavioral Biology Program, McLean Hospital/Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USABehavioral Biology Program, McLean Hospital/Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USACenter for Substance Abuse Research, Lewis Katz School of Medicine of Temple University, 3500 N. Broad St., Philadelphia, PA 19140, USACenter for Substance Abuse Research, Lewis Katz School of Medicine of Temple University, 3500 N. Broad St., Philadelphia, PA 19140, USACenter for Substance Abuse Research, Lewis Katz School of Medicine of Temple University, 3500 N. Broad St., Philadelphia, PA 19140, USADepartment of Health and Human Services, Psychobiology Section, Molecular Neuropsychiatry Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USADepartment of Health and Human Services, Psychobiology Section, Molecular Neuropsychiatry Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USADepartment of Pharmacology and Edward F Domino Research Center, University of Michigan Medical School, Ann Arbor, MI 48109, USADepartment of Pharmacology and Edward F Domino Research Center, University of Michigan Medical School, Ann Arbor, MI 48109, USADepartment of Health and Human Services, Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 9800 Medical Center Drive, Bethesda, MD 20892-3373, USADepartment of Health and Human Services, Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 9800 Medical Center Drive, Bethesda, MD 20892-3373, USA(−)-<i>N</i>-Phenethyl analogs of optically pure <i>N</i>-norhydromorphone were synthesized and pharmacologically evaluated in several in vitro assays (opioid receptor binding, stimulation of [<sup>35</sup>S]GTPγS binding, forskolin-induced cAMP accumulation assay, and MOR-mediated β-arrestin recruitment assays). “Body” and “tail” interactions with opioid receptors (a subset of Portoghese’s message-address theory) were used for molecular modeling and simulations, where the “address” can be considered the “body” of the hydromorphone molecule and the “message” delivered by the substituent (tail) on the aromatic ring of the <i>N</i>-phenethyl moiety. One compound, <i>N</i>-<i>p</i>-chloro-phenethynorhydromorphone ((7a<i>R</i>,12b<i>S</i>)-3-(4-chlorophenethyl)-9-hydroxy-2,3,4,4a,5,6-hexahydro-1<i>H</i>-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7a<i>H</i>)-one, <b>2i</b>), was found to have nanomolar binding affinity at MOR and DOR. It was a potent partial agonist at MOR and a full potent agonist at DOR with a δ/μ potency ratio of 1.2 in the ([<sup>35</sup>S]GTPγS) assay. Bifunctional opioids that interact with MOR and DOR, the latter as agonists or antagonists, have been reported to have fewer side-effects than MOR agonists. The <i>p</i>-chlorophenethyl compound <b>2i</b> was evaluated for its effect on respiration in both mice and squirrel monkeys. Compound <b>2i</b> did not depress respiration (using normal air) in mice or squirrel monkeys. However, under conditions of hypercapnia (using air mixed with 5% CO<sub>2</sub>), respiration was depressed in squirrel monkeys.https://www.mdpi.com/1420-3049/25/11/2640opioidbifunctional ligands(−)-<i>N</i>-phenethylnorhydromorphone analogs[<sup>35</sup>S]GTPgammaS assayforskolin-induced cAMP accumulation assaysβ-arrestin recruitment assays
spellingShingle Meining Wang
Thomas C. Irvin
Christine A. Herdman
Ramsey D. Hanna
Sergio A. Hassan
Yong-Sok Lee
Sophia Kaska
Rachel Saylor Crowley
Thomas E. Prisinzano
Sarah L. Withey
Carol A. Paronis
Jack Bergman
Saadet Inan
Ellen B. Geller
Martin W. Adler
Theresa A. Kopajtic
Jonathan L. Katz
Aaron M. Chadderdon
John R. Traynor
Arthur E. Jacobson
Kenner C. Rice
The Intriguing Effects of Substituents in the <i>N</i>-Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of “Tail Wags Dog” Experiments
Molecules
opioid
bifunctional ligands
(−)-<i>N</i>-phenethylnorhydromorphone analogs
[<sup>35</sup>S]GTPgammaS assay
forskolin-induced cAMP accumulation assays
β-arrestin recruitment assays
title The Intriguing Effects of Substituents in the <i>N</i>-Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of “Tail Wags Dog” Experiments
title_full The Intriguing Effects of Substituents in the <i>N</i>-Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of “Tail Wags Dog” Experiments
title_fullStr The Intriguing Effects of Substituents in the <i>N</i>-Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of “Tail Wags Dog” Experiments
title_full_unstemmed The Intriguing Effects of Substituents in the <i>N</i>-Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of “Tail Wags Dog” Experiments
title_short The Intriguing Effects of Substituents in the <i>N</i>-Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of “Tail Wags Dog” Experiments
title_sort intriguing effects of substituents in the i n i phenethyl moiety of norhydromorphone a bifunctional opioid from a set of tail wags dog experiments
topic opioid
bifunctional ligands
(−)-<i>N</i>-phenethylnorhydromorphone analogs
[<sup>35</sup>S]GTPgammaS assay
forskolin-induced cAMP accumulation assays
β-arrestin recruitment assays
url https://www.mdpi.com/1420-3049/25/11/2640
work_keys_str_mv AT meiningwang theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT thomascirvin theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT christineaherdman theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT ramseydhanna theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT sergioahassan theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT yongsoklee theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT sophiakaska theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT rachelsaylorcrowley theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT thomaseprisinzano theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT sarahlwithey theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT carolaparonis theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT jackbergman theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT saadetinan theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT ellenbgeller theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT martinwadler theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT theresaakopajtic theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT jonathanlkatz theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT aaronmchadderdon theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT johnrtraynor theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT arthurejacobson theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT kennercrice theintriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT meiningwang intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT thomascirvin intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT christineaherdman intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT ramseydhanna intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT sergioahassan intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT yongsoklee intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT sophiakaska intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT rachelsaylorcrowley intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT thomaseprisinzano intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT sarahlwithey intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT carolaparonis intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT jackbergman intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT saadetinan intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT ellenbgeller intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT martinwadler intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT theresaakopajtic intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT jonathanlkatz intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT aaronmchadderdon intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT johnrtraynor intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT arthurejacobson intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments
AT kennercrice intriguingeffectsofsubstituentsintheiniphenethylmoietyofnorhydromorphoneabifunctionalopioidfromasetoftailwagsdogexperiments